Home » LONZA, BMS CONFIRM COMMITMENT TO PORTSMOUTH PLANT
LONZA, BMS CONFIRM COMMITMENT TO PORTSMOUTH PLANT
Swiss chemicals group Lonza Group AG and Bristol-Myers Squibb Co confirmed that their current long-term agreement for the large-scale production plant in Portsmouth, New Hampshire, is unchanged. The two companies made the statement after an earlier Bristol-Myers announcement saying it has signed a long-term production agreement with South Korean biopharma group Celltrion, sparked doubts about Bristol's commitment to its agreement with Lonza.
()a href="http://www.forbes.com/markets/feeds/afx/2005/06/22/afx2105171.html" target="_blank">Forbes
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May